301 related articles for article (PubMed ID: 32292520)
1. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
2. AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.
Liao R; Chen X; Cao Q; Bai L; Ma C; Dai Z; Dong C
Breast Cancer Res; 2024 Apr; 26(1):70. PubMed ID: 38654332
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.
Liao WC; Lin TJ; Liu YC; Wei YS; Chen GY; Feng HP; Chang YF; Chang HT; Wang CL; Chi HC; Wang CI; Lin KH; Ou Yang WT; Yu CJ
Cancer Sci; 2022 Jan; 113(1):205-220. PubMed ID: 34773335
[TBL] [Abstract][Full Text] [Related]
4. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Zhou S; Xu J; Zhu Y
Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
[TBL] [Abstract][Full Text] [Related]
6. Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca
Chen X; Cao Q; Liao R; Wu X; Xun S; Huang J; Dong C
Theranostics; 2019; 9(1):34-47. PubMed ID: 30662552
[TBL] [Abstract][Full Text] [Related]
7. Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.
Miao Z; Cao Q; Liao R; Chen X; Li X; Bai L; Ma C; Deng X; Dai Z; Li J; Dong C
J Exp Clin Cancer Res; 2022 May; 41(1):169. PubMed ID: 35526049
[TBL] [Abstract][Full Text] [Related]
8. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
9. STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3.
Han W; Carpenter RL; Cao X; Lo HW
Mol Carcinog; 2013 Dec; 52(12):959-69. PubMed ID: 22693070
[TBL] [Abstract][Full Text] [Related]
10. Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
Cui W; Li SY; Du JF; Zhu ZM; An P
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):393-400. PubMed ID: 22893466
[TBL] [Abstract][Full Text] [Related]
11. Induction of PLSCR1 in a STING/IRF3-dependent manner upon vector transfection in ovarian epithelial cells.
Kodigepalli KM; Nanjundan M
PLoS One; 2015; 10(2):e0117464. PubMed ID: 25658875
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and interferon tau regulate DDX58 and PLSCR1 in the ovine uterus during the peri-implantation period.
Song G; Fleming JA; Kim J; Spencer TE; Bazer FW
Reproduction; 2011 Jan; 141(1):127-38. PubMed ID: 20926691
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK.
Zhao KW; Li D; Zhao Q; Huang Y; Silverman RH; Sims PJ; Chen GQ
J Biol Chem; 2005 Dec; 280(52):42707-14. PubMed ID: 16260419
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-αVβ5 axis.
Cao Q; Chen X; Wu X; Liao R; Huang P; Tan Y; Wang L; Ren G; Huang J; Dong C
J Exp Med; 2018 Jun; 215(6):1679-1692. PubMed ID: 29728441
[TBL] [Abstract][Full Text] [Related]
15. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.
Wu X; Li X; Fu Q; Cao Q; Chen X; Wang M; Yu J; Long J; Yao J; Liu H; Wang D; Liao R; Dong C
J Exp Med; 2017 Apr; 214(4):1065-1079. PubMed ID: 28270406
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings.
Pan CM; Wang ML; Chiou SH; Chen HY; Wu CW
Oncotarget; 2016 Sep; 7(37):60395-60406. PubMed ID: 27486982
[TBL] [Abstract][Full Text] [Related]
18. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
19. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
20. HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.
Liao R; Chen X; Cao Q; Wang Y; Miao Z; Lei X; Jiang Q; Chen J; Wu X; Li X; Li J; Dong C
Front Oncol; 2021; 11():780094. PubMed ID: 34746019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
